top of page
Release Therapeutics Announces New CEO to Advance Groundbreaking Treatment for Brain Disorders (30 January 2025)
Dr. Julien Grogg will Lead the Company's Transition to Clinical Development Building on Promising Primate Study GENEVA, 30 January, 2025...
Jan 303 min read
168
0
Press Release: Release Therapeutics Announces New CEO to Drive Best-in-Class CNS Innovation
Release Tx Announces New CEO, aligning with the company’s recent pivot towards treating genetic disorders of the CNS without gene therapy
Jun 27, 20242 min read
119
0
Treating Genetic Disorders of the CNS without Gene Therapy (or what we’ve been up to here at Release Therapeutics)
Release Therapeutics' strategic pivot towards treating genetic disorders of the central nervous system without gene therapy.
Jun 15, 20246 min read
204
0
MaxiVAX transitions into Release Tx
We are pleased to announce that, with the recent progress in the development of its unique platform technology, MaxiVAX is morphing into...
Sep 15, 20231 min read
97
0
bottom of page